InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by LEONARD JOHN M, Chief Executive Officer. Director active across 2 companies, notably Intellia Therapeutics, Inc.. In total, 8 reports have been published. The latest transaction was disclosed on 11 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations8 total
0995 shares0
Common Stock
SEC:0001478242-22-000072:0·
7,848 shares
Common Stock
SEC:0001209191-22-016537:0·
€132,18411,637 shares@ €11.35890.0069% mcap18.8% of flow
Common Stock
SEC:0001209191-21-054331·
€132,18411,637 shares@ €11.35890.0069% mcap9.4% of flow
Common Stock
SEC:0001209191-21-054331:0·
€309,64427,139 shares@ €11.40960.016% mcap44.1% of flow
Common Stock
SEC:0001209191-21-053305·
€309,64427,139 shares@ €11.40960.016% mcap22.1% of flow
Common Stock
SEC:0001209191-21-053305:0·
€260,29722,682 shares@ €11.47590.014% mcap37.1% of flow
Common Stock
SEC:0001209191-21-052835·
€260,29722,682 shares@ €11.47590.014% mcap18.5% of flow
Common Stock
SEC:0001209191-21-052835:0·
8 of 8 declarations
About LEONARD JOHN M
John M. Leonard serves as President and Chief Executive Officer of Intellia Therapeutics, Inc. and IQVIA Holdings Inc. He leads the operations of both companies, focusing on innovation in biotechnology and health services. Intellia Therapeutics specializes in gene therapy, while IQVIA focuses on health data and analytics.
